# OnCo record eisai (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/eisai/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "eisai" ;
  schema:name "Eisai"@en ;
  schema:description "Japanese pharma that makes lenvatinib (Lenvima), a first-line option in liver cancer and a partner of pembrolizumab in several tumours."@en ;
  schema:url <https://onco.cc/companies/eisai/>, <https://www.eisai.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Eisai_(company)> ;
  owl:sameAs <http://www.wikidata.org/entity/Q903384> ;
  schema:citation <https://www.eisai.com> ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/endometrial/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/farletuzumab-ecteribulin/>, <https://onco.cc/drugs/alitretinoin/>, <https://onco.cc/drugs/pilocarpine/> ;
  onco:trials <https://onco.cc/trials/nct04008797/>, <https://onco.cc/trials/nct04078295/>, <https://onco.cc/trials/nct04586231/>, <https://onco.cc/trials/nct05899049/> .